New pill takes on Hard-to-Treat blood cancers in early trial
NCT ID NCT06846606
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This early-phase study tests an experimental oral drug, AUTX-703, in adults whose acute myeloid leukemia or myelodysplastic syndromes have returned or not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug shows any signs of controlling the disease. About 34 participants will take part across multiple centers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
H Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10021, United States
-
Ohio State University, The James Comprehensive Cancer
Columbus, Ohio, 43210, United States
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14203, United States
-
Sarah Cannon Center for Blood Cancer at TriStar Centennia
Nashville, Tennessee, 37203, United States
-
UPENN Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, 19104, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27514, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.